chr2-230210491-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_080424.4(SP110):​c.752-483C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.126 in 152,214 control chromosomes in the GnomAD database, including 1,372 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars).

Frequency

Genomes: 𝑓 0.13 ( 1372 hom., cov: 32)

Consequence

SP110
NM_080424.4 intron

Scores

2

Clinical Significance

Uncertain significance no assertion criteria provided U:1

Conservation

PhyloP100: -1.21

Publications

9 publications found
Variant links:
Genes affected
SP110 (HGNC:5401): (SP110 nuclear body protein) The nuclear body is a multiprotein complex that may have a role in the regulation of gene transcription. This gene is a member of the SP100/SP140 family of nuclear body proteins and encodes a leukocyte-specific nuclear body component. The protein can function as an activator of gene transcription and may serve as a nuclear hormone receptor coactivator. In addition, it has been suggested that the protein may play a role in ribosome biogenesis and in the induction of myeloid cell differentiation. Alternative splicing has been observed for this gene and three transcript variants, encoding distinct isoforms, have been identified. [provided by RefSeq, Jul 2008]
SP140 (HGNC:17133): (SP140 nuclear body protein) This gene encodes a member of the SP100 family of proteins, which are share common domains including an N-terminal homogeneously staining region domain followed by a SP100/autoimmune regulator/NucP41/P75/deformed epidermal autoregulatory factor domain, a plant homeobox zinc finger, and a bromodomain. The encoded protein is interferon-inducible and is expressed at high levels in the nuclei of leukocytes. Variants of this gene have been associated with multiple sclerosis, Crohn's disease, and chronic lymphocytic leukemia. Alternative splicing results in multiple variants. [provided by RefSeq, Aug 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.258 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_080424.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SP110
NM_080424.4
MANE Select
c.752-483C>T
intron
N/ANP_536349.3Q9HB58-6
SP110
NM_001378442.1
c.770-483C>T
intron
N/ANP_001365371.1
SP110
NM_001378443.1
c.752-483C>T
intron
N/ANP_001365372.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SP110
ENST00000258381.11
TSL:2 MANE Select
c.752-483C>T
intron
N/AENSP00000258381.6Q9HB58-6
SP110
ENST00000358662.9
TSL:1
c.752-483C>T
intron
N/AENSP00000351488.4Q9HB58-1
SP110
ENST00000258382.10
TSL:1
c.752-483C>T
intron
N/AENSP00000258382.5Q9HB58-3

Frequencies

GnomAD3 genomes
AF:
0.126
AC:
19169
AN:
152096
Hom.:
1367
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.169
Gnomad AMI
AF:
0.0811
Gnomad AMR
AF:
0.0826
Gnomad ASJ
AF:
0.185
Gnomad EAS
AF:
0.182
Gnomad SAS
AF:
0.271
Gnomad FIN
AF:
0.0628
Gnomad MID
AF:
0.187
Gnomad NFE
AF:
0.102
Gnomad OTH
AF:
0.126
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.126
AC:
19191
AN:
152214
Hom.:
1372
Cov.:
32
AF XY:
0.126
AC XY:
9382
AN XY:
74410
show subpopulations
African (AFR)
AF:
0.169
AC:
7033
AN:
41498
American (AMR)
AF:
0.0825
AC:
1263
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.185
AC:
643
AN:
3472
East Asian (EAS)
AF:
0.182
AC:
942
AN:
5178
South Asian (SAS)
AF:
0.270
AC:
1303
AN:
4824
European-Finnish (FIN)
AF:
0.0628
AC:
666
AN:
10612
Middle Eastern (MID)
AF:
0.190
AC:
56
AN:
294
European-Non Finnish (NFE)
AF:
0.102
AC:
6948
AN:
68012
Other (OTH)
AF:
0.125
AC:
263
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
851
1702
2554
3405
4256
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
224
448
672
896
1120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.120
Hom.:
690
Bravo
AF:
0.126
Asia WGS
AF:
0.208
AC:
723
AN:
3478

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:no assertion criteria provided
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Mycobacterium tuberculosis, susceptibility to (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.10
DANN
Benign
0.37
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2114592; hg19: chr2-231075206; API